血管性血友病因子破坏与连续流循环辅助装置
连续流左心室辅助装置(VAD)出血事件频繁且显著。血管性血友病因子(VWF)通过桥接血小板黏附与聚集维持止血。临床与实验数据支持获得性血管性血友病在VAD出血中起作用,由剪切诱导的VWF定性缺陷引起。病理剪切通过ADAMTS13使VWF展开并蛋白水解大分子量多聚体为较小止血功能较低的多聚体。本综述概述VAD背景下VWF破坏的病理生物学及获得性血管性血友病的诊断与管理策略。
要点
- 连续流VAD患者出血事件频繁,获得性血管性血友病是重要机制。
- 病理剪切通过ADAMTS13导致VWF多聚体蛋白水解,止血功能下降。
- 综述涵盖VAD相关VWF破坏的病理生物学、诊断与管理策略。
核心结论
- 获得性血管性血友病参与连续流VAD出血事件,由剪切诱导的VWF定性缺陷引起。
- 病理剪切通过ADAMTS13使VWF大分子量多聚体蛋白水解为较小止血功能较低的多聚体。
研究设计与样本
- 综述,总结VAD背景下VWF破坏的病理生物学及获得性血管性血友病的诊断与管理策略。
主要发现
- 临床与实验数据支持获得性血管性血友病在VAD出血发作中的作用。
- 病理剪切诱导VWF展开并通过ADAMTS13蛋白水解大分子量多聚体。
临床怎么用
- 综述概述VAD相关获得性血管性血友病的当前诊断与管理策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Bleeding events remain a significant and frequent complication of continuous-flow left ventricular assist devices (VADs). von Willebrand factor (VWF) is critical to hemostasis by acting as a bridging molecule at sites of vascular injury for normal platelet adhesion as well as promoting platelet aggregation under conditions of high shear. Clinical and experimental data support a role for acquired von Willebrand disease in VAD bleeding episodes caused by shear-induced qualitative defects in VWF. Pathologic shear induces VWF unfolding and proteolysis of large multimers into smaller less hemostatic multimers via ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13). This review outlines the pathobiology of VWF disruption in the context of VADs as well as current diagnostic and management strategies of the associated acquired von Willebrand disease.
引用
- Proudfoot AG, Davidson SJ, Strueber M, et al. von Willebrand factor disruption and continuous-flow circulatory devices. J Heart Lung Transplant. 2017. PMID: 28756118. doi:10.1016/j.healun.2017.06.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。